Skip to main content

Advertisement

Log in

Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The combination of morphine and gabapentin seems promising for the treatment of postoperative and neuropathic pain. Despite the well characterised pharmacodynamic interaction, little is known about possible pharmacokinetic interactions. The aim of this study was to evaluate whether co-administration of the two drugs leads to modifications of their pharmacokinetic profiles.

Methods

The pharmacokinetics of morphine, morphine-3-glucuronide and gabapentin were characterised in rats following subcutaneous injections of morphine, gabapentin or their combination. Non-linear mixed effects modelling was applied to describe the pharmacokinetics of the compounds and possible interactions.

Results

The plasma-concentration-time profiles of morphine and gabapentin were best described using a three- and a one-compartment disposition model respectively. Dose dependencies were found for morphine absorption rate and gabapentin bioavailability. Enterohepatic circulation of morphine-3-glucuronide was modelled using an oscillatory model. The combination did not lead to pharmacokinetic interactions for morphine or gabapentin but resulted in an estimated ~33% diminished morphine-3-glucuronide formation.

Conclusions

The finding of a lack of pharmacokinetic interaction strengthens the notion that the combination of the two drugs leads to better efficacy in pain treatment due to interaction at the pharmacodynamic level. The interaction found between gabapentin and morphine-3-glucuronide, the latter being inactive, might not have any clinical relevance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

EHC:

Enterohepatic circulation

M3G:

Morphine-3-Glucuronide

M6G:

Morphine-6-Glucuronide

MS/MS:

Tandem mass spectrometry

NONMEM:

Non-linear mixed effects modelling

OFV:

Objective function value

UPLC:

Ultra-high-performance liquid chromatography

VPC:

Visual predictive check

References

  1. Dahl JB, Mathiesen O, Kehlet H. An expert opinion on postoperative pain management, with special reference to new developments. Expert Opin Pharmacother. 2010;11(15):2459–70.

    Article  CAS  PubMed  Google Scholar 

  2. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010. p. 807–19.

  3. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane database Syst Rev. 2013;8.

  4. Taylor CP. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cava2-δ] ligands. Pain Int Assoc Stud Pain. 2009;142(1-2):13–6.

    CAS  Google Scholar 

  5. Rose MA, Kam PCA. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002. p. 451–62.

  6. Bennett M, Simpson K. Gabapentin in the treatment of neuropathic pain. Palliat Med. 2004;18:5–11.

    Article  PubMed  Google Scholar 

  7. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996. p. 56–8.

  8. Lunn TH, Husted H, Laursen MB, Hansen LT, Kehlet H. Analgesic and sedative effects of perioperative gabapentin in total knee arthroplasty. A randomized, double-blind, placebo-controlled, dose-finding study. Pain. 2015;156:1.

    Article  Google Scholar 

  9. Kong VKF, Irwin MG. Gabapentin: a multimodal perioperative drug? Br J Anaesth. 2007;99(6):775–86.

    Article  CAS  PubMed  Google Scholar 

  10. Mathiesen O, Møiniche S, Dahl JB. Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure. BMC Anesthesiol. 2007;7:6.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain. 1997;72(3):375–82.

    Article  CAS  PubMed  Google Scholar 

  12. Matthews E, Dickenson A. A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology. 2002;96(3):633–40.

    Article  CAS  PubMed  Google Scholar 

  13. Smiley MM, Lu Y, Vera-Portocarrero LP, Zidan A, Westlund KN. Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model. Anesthesiology. 2004;101(3):759–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Papathanasiou T, Juul RV, Heegaard A-M, Kreilgaard M, Lund TM. Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain. Eur J Pharm Sci. 2016;82:97–105.

    Article  CAS  PubMed  Google Scholar 

  15. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manag. 2007;34:183–9.

    Article  CAS  Google Scholar 

  16. Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. 2002;97(22000947):560–4.

  17. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20:456–72.

    Article  PubMed  Google Scholar 

  18. Gilron I, Bailey J, Tu D, Tesfaye S, Selvarajah D. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352(25):2650–1.

    Article  Google Scholar 

  19. Ouellet DM, Pollack GM. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. Drug Metab Dispos. 1995;23(4):478–84.

    CAS  PubMed  Google Scholar 

  20. De la O-Arciniega M, Díaz-Reval MI, Cortés-Arroyo AR, Domínguez-Ramírez AM, López-Muñoz FJ. Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury. Pharmacol Biochem Behav. 2009;92(3):457–64.

    Article  PubMed  Google Scholar 

  21. Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, et al. Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther. 2008;83(3):416–21.

    Article  CAS  PubMed  Google Scholar 

  22. Keizer RJ, Karlsson MO, Hooker A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013;2(November 2012):e50.

  23. Sverrisdóttir E, Lund TM, Olesen AE, Drewes AM, Christrup LL, Kreilgaard M. A review of morphine and morphine-6-glucuronide’s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain. Eur J Pharm Sci. 2015;74:45–62.

    Article  PubMed  Google Scholar 

  24. Beal S, Sheiner L, Boeckmann A, Bauer R. NONMEM user’s guides. (1989-2009). Icon Dev Solut Ellicott City, MD, USA, 2009.

  25. Team R. R Development Core Team. R A Lang Environ Stat Comput. 2013.

  26. Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3(2):180–5.

    Article  Google Scholar 

  27. Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143–51.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Wajima T, Yano Y, Oguma T. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation. J Pharm Pharmacol. 2002;54:929–34.

    Article  CAS  PubMed  Google Scholar 

  29. Lehr T, Staab A, Tillmann C, Trommeshauser D, Schaefer HG, Kloft C. A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam. Clin Pharmacokinet. 2009;48(8):529–42.

    Article  CAS  PubMed  Google Scholar 

  30. Bouw MR, Gårdmark M, Hammarlund-Udenaes M. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study. Pharm Res. 2000;17(10):1220–7.

    Article  CAS  PubMed  Google Scholar 

  31. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg. 2000;91(1):185–91.

    CAS  PubMed  Google Scholar 

  32. Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet. 2002;41(10):751–90.

    Article  CAS  PubMed  Google Scholar 

  33. Huntjens DRH, Strougo A, Chain A, Metcalf A, Summerfield S, Spalding DJM, et al. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. Br J Pharmacol. 2008;153(5):1072–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Taneja A, Nyberg J, de Lange ECM, Danhof M, Della Pasqua O. Application of ED-optimality to screening experiments for analgesic compounds in an experimental model of neuropathic pain. J Pharmacokinet Pharmacodyn. 2012;39(6):673–81.

    Article  CAS  PubMed  Google Scholar 

  35. Larsen MS, Keizer R, Munro G, Mørk A, Holm R, Savic R, et al. Pharmacokinetic/Pharmacodynamic relationship of gabapentin in a CFA-induced inflammatory hyperalgesia rat model. Pharm Res. 2016;1–11.

  36. Ekblom M. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Drug Dispos. 1993;14:1–11.

    Article  CAS  Google Scholar 

  37. Dahlström BE, Paalzow LK. Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J Pharmacokinet Biopharm. 1978;6(6):505–19.

    Article  PubMed  Google Scholar 

  38. Mazoit JX, Butscher K, Samii K. Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites. Anesth Analg. 2007;105:70–8.

    Article  CAS  PubMed  Google Scholar 

  39. Chen C, Upward J, Arumugham T, Stier B, Davy M. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison. Clin Ther. 2015;37(2):349–57.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Trine Meldgaard Lund.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papathanasiou, T., Juul, R.V., Gabel-Jensen, C. et al. Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat. Pharm Res 33, 2630–2643 (2016). https://doi.org/10.1007/s11095-016-1988-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-016-1988-z

KEY WORDS

Navigation